P-Alaxin TS Tablets
Overview
P-Alaxin TS Tablets are used for the treatment of uncomplicated malaria. This medication combines two active ingredients: Dihydroartemisinin (120mg) and Piperaquine Phosphate (960mg), which work synergistically to eliminate malaria parasites from the body.
Key Features
- Active Ingredients: Each tablet contains Dihydroartemisinin 120mg and Piperaquine Phosphate 960mg.
- Effective Treatment: Specifically formulated for treating uncomplicated malaria caused by Plasmodium falciparum and Plasmodium vivax.
- Three-Day Course: Typically, the treatment involves taking one tablet daily for three days.
Benefits
- Potent Antimalarial Action: The combination of Dihydroartemisinin and Piperaquine provides a powerful effect against malaria parasites.
- Convenient Dosage: The three-day regimen ensures patient compliance and effectiveness.
- Rapid Relief: Helps alleviate malaria symptoms quickly, such as fever, chills, and muscle pain.
Usage Instructions
- Dosage: Take one tablet daily for three days. It is recommended to take the tablet after food to enhance absorption and minimize gastrointestinal discomfort.
- Administration: Swallow the tablet with water. Follow your healthcare provider’s instructions precisely.
Precautions
- Pregnancy and Breastfeeding: Not recommended during the first trimester of pregnancy due to potential risks. Consult your doctor if you are pregnant or breastfeeding.
- Drug Interactions: Inform your healthcare provider about any other medications or supplements you are taking, as P-Alaxin TS can interact with drugs such as CYP3A4 inhibitors.
- Side Effects: Possible side effects include abdominal pain, nausea, vomiting, dizziness, and headache. Contact your doctor if side effects persist or worsen.
Storage
- Conditions: Store in a cool, dry place below 30°C and protect from light. Keep out of reach of children.
P-Alaxin TS Tablets provide an effective and convenient option for treating uncomplicated malaria, ensuring rapid relief and compliance with a short treatment course.